Related Experiment Video
Updated: Jul 8, 2025
04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
708
Hypnosis Intervention for Sleep Disturbances in Individuals with Mild Cognitive Impairment: A Randomized Pilot Study
Gary Elkins1, Victor J Padilla1, Julie Otte2
1Department of Psychology and Neuroscience, Baylor University, Waco, Texas, USA.
The International Journal of Clinical and Experimental Hypnosis
|December 15, 2023
Summary
Self-administered hypnosis is a feasible, non-pharmacological option for improving sleep quality in adults with mild cognitive impairment (MCI). This pilot study found hypnosis significantly enhanced sleep duration and reduced daytime sleepiness in MCI patients.
Area of Science:
- Neurology
- Sleep Medicine
- Psychology
Background:
- Poor sleep quality is common in mild cognitive impairment (MCI), linked to decreased quality of life and dementia progression.
- Current pharmacological sleep aids for MCI have limited efficacy and risks.
- Non-pharmacological interventions are needed to improve sleep in adults with MCI.
Purpose of the Study:
- To assess the feasibility and adherence of a self-administered hypnosis intervention for sleep quality in adults with MCI.
- To evaluate the impact of hypnosis on sleep quality, pain, and stress in individuals with MCI.
Main Methods:
- A two-armed randomized controlled pilot trial involving 21 adults with MCI.
- Participants listened to hypnosis or sham hypnosis audio recordings for five weeks.
- Feasibility, adherence, pain, stress, and sleep quality were measured via logs, questionnaires, and actigraphy.
Main Results:
- Hypnosis intervention showed high participant satisfaction, ease of use, and perceived effectiveness.
- Adherence to the hypnosis program was within acceptable levels, with no adverse events reported.
- Significant improvements in sleep quality, sleep duration, and reduced daytime sleepiness were observed in the hypnosis group.
Conclusions:
- Self-administered hypnosis is a feasible and well-tolerated intervention for improving sleep in adults with MCI.
- Hypnosis shows promise as a non-pharmacological approach to manage sleep disturbances in MCI.
- Further research is warranted to explore the long-term effects of hypnosis on sleep and cognitive health in MCI.
Related Concept Videos
01:19Management of Insomnia
255
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
255
01:27Insomnia
87
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
87
01:17Sleepwalking and Sleep Talking
168
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
168
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
179
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
179
01:23Sedatives and Hypnotics: Overview
397
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
397
01:14CNS Depressants: Barbiturates and Benzodiazepines
278
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
278